Imbio RV/LV Software vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Ligence

AI Verdict

Imbio RV/LV Software and Ligence Heart are adjacent competitors within the Cardiology AI space, but they are not direct substitutes. Imbio specializes in automated right and left ventricular measurements from CTPA scans for pulmonary condition risk stratification, while Ligence Heart focuses on comprehensive automated analysis and reporting of 2D transthoracic echocardiography for a broader range of cardiac diagnostics.

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your primary need is rapid, automated assessment of right and left ventricular dimensions from CTPA scans. This tool is ideal for radiology departments requiring quick risk stratification for pulmonary conditions, such as suspected pulmonary embolism, by providing an automated RV/LV ratio. It streamlines the workflow by integrating directly with standard reading environments and generating summary reports without user intervention.

View Imbio RV/LV Software →

Choose Ligence Heart if…

Choose Ligence Heart if your focus is on comprehensive, automated analysis and reporting of 2D transthoracic echocardiography studies. This platform is best suited for cardiology departments aiming to enhance diagnostic efficiency and accuracy across a wide range of cardiac conditions, including heart failure and valvular diseases. It automates view classification, heart phase prediction, various quantitative measurements, and disease recognition, significantly reducing manual effort for cardiologists and sonographers.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio RV/LV Software Ligence Heart
Pricing Unknown Contact-for-pricing
Deployment Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] Cloud-based; on-premise; hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio RV/LV Software Ligence Heart
Primary Function AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers.
Company Imbio Ligence
Input Data Type CTPA scans 2D transthoracic echocardiography imaging data
Key Analytical Capabilities Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio, artificial intelligence algorithm for ventricle identification and measurement, annotated images showing ventricular measurements, generates summary PDF reports. Automated recognition of echocardiography imaging data, automated view classification and heart phase prediction, automated calculation of measurements and report generation, Area, Distance, Doppler, and Volume quantification, disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), automated strain, Spectral and Tissue Doppler measurements.
Specialties Supported Cardiology, Pulmonology, Radiology Cardiology
Integration DICOM compliant input and output, integration with standard reading environments (PACS). Integration with existing systems (PACS, EHR, RIS).

Videos

Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and Ligence Heart.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio RV/LV Software analyzes CTPA scans to measure right and left ventricular diameters. Ligence Heart, on the other hand, automates the analysis and reporting of 2D transthoracic echocardiography imaging data.
Imbio RV/LV Software provides an RV/LV ratio to aid in risk stratification for pulmonary conditions, such as pulmonary embolism. Ligence Heart enhances diagnostic efficiency and accuracy for cardiologists by offering automated measurements and disease recognition for conditions like heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases.
Imbio RV/LV Software is relevant for Cardiology, Pulmonology, and Radiology specialties. Ligence Heart is primarily focused on supporting Cardiology.
Imbio RV/LV Software offers DICOM compliant input and output and integrates with standard reading environments like PACS, also supporting deployment via partner platforms. Ligence Heart integrates with existing systems such as PACS, EHR, and RIS, and transfers echocardiography images with PHI removed.
Imbio RV/LV Software automatically measures right and left ventricular diameters and calculates the RV/LV ratio from CTPA scans. Ligence Heart performs automated view classification, heart phase prediction, and quantifies Area, Distance, Doppler, Volume, Strain, Spectral, and Tissue Doppler measurements from echocardiography.
AI Tool Finder
AI-powered search. Results may not be comprehensive.